CN Patent

CN116410133A — 一种氟伐替尼氢溴酸盐及其制备方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2023-07-11 · 3y expired

What this patent protects

本发明公开氟伐替尼氢溴酸盐及其制备方法，该氟伐替尼氢溴酸盐具有良好的溶出特性。同时，本发明进一步包含氟伐替尼氢溴酸盐的晶型形式，尤其是晶型III同时具有晶型稳定和不易产生基因毒性的优势，具有非常好的成药性和安全性。

USPTO Abstract

本发明公开氟伐替尼氢溴酸盐及其制备方法，该氟伐替尼氢溴酸盐具有良好的溶出特性。同时，本发明进一步包含氟伐替尼氢溴酸盐的晶型形式，尤其是晶型III同时具有晶型稳定和不易产生基因毒性的优势，具有非常好的成药性和安全性。

Drugs covered by this patent

Patent Metadata

Patent number
CN116410133A
Jurisdiction
CN
Classification
—
Expires
2023-07-11
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.